| 1 |
33839989 | Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients. | 2022 Mar |
1 |
| 2 |
35063963 | Effect of perioperative levosimendan administration on postoperative N-terminal pro-B-type natriuretic peptide concentration in patients with increased cardiovascular risk factors undergoing non-cardiac surgery: protocol for the double-blind, randomised, placebo-controlled IMPROVE trial. | 2022 Jan 21 |
1 |
| 3 |
35083882 | Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients. | 2022 Apr |
2 |
| 4 |
35350988 | Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study. | 2022 Mar 29 |
4 |
| 5 |
32462455 | Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials. | 2021 Jan |
3 |
| 6 |
34588413 | Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement. | 2021 Sep 30 |
1 |
| 7 |
33269816 | Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure. | 2020 Nov |
3 |
| 8 |
29637229 | Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis. | 2019 Nov |
1 |
| 9 |
29548887 | Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with Levosimendan. | 2018 Jun |
1 |
| 10 |
27138236 | Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial. | 2016 May 3 |
1 |
| 11 |
26082815 | Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study. | 2015 Dec |
2 |
| 12 |
27708855 | Levosimendan improves exercise performance in patients with advanced chronic heart failure. | 2015 Sep |
2 |
| 13 |
24699010 | Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure. | 2014 Apr |
1 |
| 14 |
23490237 | Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction. | 2013 Apr |
1 |
| 15 |
22870740 | The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure. | 2012 Jun |
1 |
| 16 |
22928945 | The clinical effects of levosimendan are not attenuated by sulfonylureas. | 2012 Dec |
1 |
| 17 |
22932705 | Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. | 2012 Nov |
1 |
| 18 |
21358614 | Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients. | 2011 Feb 25 |
3 |
| 19 |
18973957 | Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. | 2010 Feb 18 |
3 |
| 20 |
20335355 | Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. | 2010 Apr |
2 |
| 21 |
19539144 | Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. | 2009 Jun 23 |
1 |
| 22 |
19812809 | Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure. | 2009 Oct |
2 |
| 23 |
19861257 | [Effect of levosimendan on B-type natriuretic peptide levels in patients with advanced heart failure: a meta-analysis]. | 2009 Oct |
6 |
| 24 |
18242130 | Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience. | 2008 Jun |
1 |
| 25 |
18501448 | The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications. | 2008 Aug 1 |
1 |
| 26 |
17596101 | Clinical pharmacology of levosimendan. | 2007 |
4 |
| 27 |
17610056 | Effects of levosimendan on quality of life and emotional stress in advanced heart failure patients. | 2007 Aug |
1 |
| 28 |
18062901 | Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure. | 2007 Dec |
1 |
| 29 |
15771921 | Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients. | 2005 Mar 30 |
2 |
| 30 |
15921958 | The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. | 2005 Aug |
2 |
| 31 |
16084762 | Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure. | 2005 Dec |
2 |
| 32 |
16306809 | Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide. | 2005 Dec |
1 |